Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,970 | 51,963 | N/A | N/A | N/A |
| Marketable Securities | 104,690 | 0 | N/A | N/A | N/A |
| TOTAL | $119,363 | $51,975 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,372 | 0 | N/A | N/A | N/A |
| Investments And Advances | 23,292 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,685 | 0 | 0 | 0 | 0 |
| TOTAL | $27,349 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $146,712 | $51,975 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,351 | 269 | 0 | 0 | 0 |
| Accrued Expenses | 9,328 | 2,180 | N/A | N/A | N/A |
| TOTAL | $13,076 | $2,449 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,287 | 66,839 | 0 | 0 | 0 |
| TOTAL | $3,287 | $66,839 | $N/A | $N/A | $N/A |
| Total Liabilities | $16,363 | $69,288 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,390 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | 1 | N/A | N/A | N/A |
| Retained earnings | -69,901 | -17,348 | N/A | N/A | N/A |
| Other shareholders' equity | 129 | 0 | 0 | 0 | 0 |
| TOTAL | $130,349 | $-17,313 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $146,712 | $51,975 | $0 | $0 | $0 |